The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Authors: Daniel J. Diekema, Po‐Ren Hsueh, Rodrigo E. Mendes, Michael A. Pfaller, Kenneth V. I. Rolston, Hélio S. Sader, Ronald N. Jones - Antimicrobial Agents and Chemotherapy 2019 cited by 639

were the predominant causes of BSI worldwide during this 20-year surveillance period. Important resistant phenotypes among Gram-positive pathogens (MRSA, VRE, or DRE) were stable or declining, whereas the prevalence of MDR-GNB increased continuously during the monitored period. MDR-GNB represent the greatest therapeutic challenge among common bacterial BSI pathogens.